Bioevaluation studies of 32P incorporated mould brachytherapy sources for potential application in treatment of superficial tumors
Usha Pandey(Bhabha Atomic Research Centre), Meera Venkatesh(Bhabha Atomic Research Centre), Ramu Ram(Bhabha Atomic Research Centre), Ashutosh Dash(Bhabha Atomic Research Centre), Haladhar Dev Sarma(Bhabha Atomic Research Centre), Grace Samuel, Sanjay Kumar Saxena(Bhabha Atomic Research Centre), Pankaj Tandon(Bhabha Atomic Research Centre)
Cited by 14
Related Papers
Production of 177Lu for Targeted Radionuclide Therapy: Available Options
|Nuclear Medicine and Molecular Imaging|2015|375
Sustained Availability of <sup>99m</sup>Tc: Possible Paths Forward
|Journal of Nuclear Medicine|2012|140
Peptide Receptor Radionuclide Therapy: An Overview
|Cancer Biotherapy and Radiopharmaceuticals|2015|122
Targeted Radionuclide Therapy - An Overview
|Current Radiopharmaceuticals|2013|117
Development of an electrochemical 90Sr–90Y generator for separation of 90Y suitable for targeted therapy
|Nuclear Medicine and Biology|2008|99